Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

Research highlights improved lung cancer biomarker testing in North America, though delays, costs, and limited satisfaction persist despite clinician awareness.